ALG1001
ALG1001 (Risuteganib, ALG-1001) is a first-in-class, RGD class oligopeptide that inhibits integrin receptors (αvβ3, αvβ5, and α5β1) associated with angiogenesis; ALG1001 inhibits an integrin-mediated pathway of the vitreoretinal interface, connecting the posterior aspect of the vitreous with the internal limiting membrane of the retina. In blocking this pathway, ALG-1001 helps to achieve vitreous breakdown and separation from the retina.
Product Specifications
CAS Number
1307293-62-4
Product Name Alternative
Risuteganib | ALG 1001 | ALG-1001
Purity
>98% (HPLC)
Smiles
O=C (O) [C@H]1N (C ([C@H] ([C@H] (O) C) NC ([C@H] (CS (=O) (O) =O) NC (CNC ([C@H] (CCCNC (N) =N) NC (CN) =O) =O) =O) =O) =O) CCC1
Molecular Formula
C22H39N9O11S
Molecular Weight
637.666
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
L-Proline, glycyl-L-arginylglycyl-3-sulfo-L-alanyl-L-threonyl-
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![CPT2 C-terminal Antibody [H24H13]](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
DJ-1B, NT (CG1349-PA, DJ-1 beta, GH09983p, dj-1-beta, dj-1 beta, dj-1beta) (MaxLight 405) (Drosophila) discontinued
